Cardiac stem cell treatment restores heart function damaged by Duchenne muscular dystrophy Late-breaking fundamental science research presented at American Heart Association Scientific Sessions displays stem cell treatment restores heart function broken by muscular disease Experts at the Cedars-Sinai Heart Institute have found that injections of cardiac stem cells will help reverse heart damage caused by Duchenne muscular dystrophy, potentially producing a longer life expectancy for patients with the chronic muscle-wasting disease http://sildenafilfr.com/le-viagra-naturel.html . The study results were presented today at a Breaking Simple Science presentation through the American Heart Association Scientific Classes in Chicago.

viagra générique

Dr.Bruce Feinberg, vice president and chief medical officer of Cardinal Health Specialty Solutions, says that physicians, payers and pharmaceutical companies as well have known for more than a decade that clinical trials only do not accurately reflect how tumor treatment happens in real life. Feinberg maintains that payers are seeing this disparity, and are adjusting reimbursement strategies as a complete result. With an elevated focus on value-based care and attention, which relies on real-world clinical proof, clinical trial data no longer provides enough information to build up appropriate reimbursement models, said Feinberg. This new research reinforces that HEOR data can help payers better understand the effectiveness of treatments in real-world configurations; and that it can be used to raised determine value-structured reimbursement strategies.